GlassScriptPhysician profile
Anusha Edara
NPI 1235542424
$7,337.04
in general payments reported to CMS, 2019-2025
45 companies · $16.47 in 2025
The $16.47 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $1,090 · 2021: $2,381 · 2022: $2,691 · 2023: $1,015 · 2024: $15.17 · 2025: $16.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $947 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $946.60 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $2,008.43 | 2020-2023 | Austedo, Austedo Xr |
| Abbvie INC. | $723.20 | 2021-2025 | Botox, Ubrelvy |
| Alexion Pharmaceuticals, INC. | $412.25 | 2020-2023 | Ultomiris, Soliris |
| Genzyme Corporation | $390.75 | 2020-2023 | |
| Ucb, INC. | $355.11 | 2019-2023 | Briviact |
| Jazz Pharmaceuticals INC. | $347.43 | 2020-2023 | |
| Allergan, INC. | $332.59 | 2020 | |
| Amgen INC. | $294.21 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $291.06 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $212.58 | 2022 | |
| Lundbeck LLC | $191.73 | 2020-2023 | Vyepti |
| Genentech USA, INC. | $171.93 | 2021-2022 | |
| Sk Life Science, INC. | $146.10 | 2020-2022 | |
| Kyowa Kirin, INC. | $136.21 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $128.44 | 2020-2023 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anusha Edara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.